What are the major opportunities in the Onchocerciasis Treatment market? What are the strategies for the Onchocerciasis Treatment market?

For detailed insights on the major opportunities and strategies in the Onchocerciasis Treatment market, Read More

How does the Onchocerciasis Treatment market relate to the overall economy and other similar markets?

For detailed insights on Onchocerciasis Treatment's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Onchocerciasis Treatment market growth? SWOT analysis of the Onchocerciasis Treatment market.

For detailed insights on the key dynamics influencing the Onchocerciasis Treatment market growth and SWOT analysis of the Onchocerciasis Treatment industry, Read More

Global Onchocerciasis Treatment Market Report 2025

Item added to cart!

Published : December 2025

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Onchocerciasis Treatment Global Market Report 2025

Name: Onchocerciasis Treatment Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Drug Type (Ivermectin, Doxycycline, Albendazole, Moxidectin), By Treatment Strategy (Mass Drug Administration (MDA), Targeted Treatment), By Mode Of Administration (Oral, Injectables, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals And Clinics, Home Care Settings, Government And Non-Governmental Programs) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Onchocerciasis Treatment Market?

Onchocerciasis treatment refers to the medical and therapeutic interventions designed to manage and eliminate onchocerca volvulus infections, which cause river blindness—a parasitic disease primarily affecting skin and eye health. The primary goal of treatment is to eliminate the microfilariae (immature larvae) and reduce transmission, symptoms, and the risk of vision loss.

The main drug types of onchocerciasis treatment are ivermectin, doxycycline, albendazole, and moxidectin. Ivermectin is an antiparasitic medication used to treat various parasitic infections, including onchocerciasis (river blindness), by killing the larvae (microfilariae) of the parasite Onchocerca volvulus. The treatment strategies include mass drug administration (MDA) and targeted treatment, with modes of administration including oral, injectable, and topical forms. The distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies and are used by various end-users such as hospitals and clinics, home care settings, and government and non-governmental programs.

Onchocerciasis Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Onchocerciasis Treatment Market Size 2025 And Growth Rate?

The onchocerciasis treatment market size has grown strongly in recent years. It will grow from $1.03 billion in 2024 to $1.11 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to an increase in patients suffering from eye-associated issues, an increase in parasitic infections, an increase in the number of targeted treatment centers, a rise in education campaigns, and an increase in the geriatric population.

What Is The Onchocerciasis Treatment Market Growth Forecast?

The onchocerciasis treatment market size is expected to see strong growth in the next few years. It will grow to $1.48 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to rising prevalence in endemic regions, rising demand for surgical procedures, expanding healthcare infrastructure, growing prevalence of chronic diseases, and increasing healthcare investments. Major trends in the forecast period include a shift towards single-dose regimens, advancements in macrocyclic lactone formulations, the emergence of Wolbachia-targeting therapies, the integration of artificial intelligence (AI) in drug discovery, and the development of pediatric-specific treatments.

Book your 30 minutes free consultation with our research experts

How Is The Onchocerciasis Treatment Market Segmented?

The onchocerciasis treatment market covered in this report is segmented –

1) By Drug Type: Ivermectin, Doxycycline, Albendazole, Moxidectin

2) By Treatment Strategy: Mass Drug Administration (MDA), Targeted Treatment

3) By Mode Of Administration: Oral, Injectables, Topical

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals And Clinics, Home Care Settings, Government And Non-Governmental Programs

Subsegments:

1) By Ivermectin: Oral Tablets, Community-Based Mass Drug Administration (MDA) Kits, Fixed-Dose Combination Therapies, Pediatric Formulations

2) By Doxycycline: Oral Capsules, Extended-Release Tablets, Combination With Anti-Wolbachia Therapy, Hospital-Based Prescription Treatments

3) By Albendazole: Single-Dose Oral Tablets, Combination Therapy With Ivermectin, Government-Supplied Preventive Chemotherapy Packages, Over-The-Counter (OTC) Formulations In Endemic Areas

4) By Moxidectin: Oral Tablets, Long-Acting Formulations, Adult-Only Dosing Regimens, Clinical Trial-Based Access Programs

What Is Driving The Onchocerciasis Treatment Market? Surge In Eye-related Conditions Fueling Growth Of The Market Due To Rising Risk Of Vision Loss

The rise in patients suffering from eye-associated issues is expected to propel the growth of the onchocerciasis treatment market going forward. Eye-associated issues refer to a variety of conditions that affect vision and ocular health, including infections, injuries, and chronic illnesses such as glaucoma or cataracts. The growth in patients suffering from eye-associated issues is primarily due to increasing screen time and prolonged exposure to digital devices. Onchocerciasis treatment helps prevent and manage vision loss and blindness in patients by eliminating the parasitic infection that causes inflammation and damage to ocular tissues. For instance, in May 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, about 20.5 million Americans over the age of 40 have cataracts in at least one eye, accounting for 17.2% of that population. It is projected that nearly 30 million people will develop cataracts by 2028. Therefore, the rising prevalence of eye-related conditions is driving growth in the onchocerciasis treatment market.

What Is Driving The Onchocerciasis Treatment Market? Surge In Surgical Interventions Fueling The Growth Of The Market Due To Rising Cases Requiring Advanced Disease Management

The rising demand for surgical procedures is expected to propel the growth of the onchocerciasis treatment market going forward. Surgical procedures refer to medical interventions aimed at removing or repairing tissues damaged by disease, often used when drug treatments are ineffective or when complications threaten long-term health. This rise is driven by the progression of onchocerciasis in some patients to advanced stages, where surgical intervention becomes necessary to prevent permanent damage, such as vision loss or disfigurement. As a result, healthcare providers are expanding surgical services and investing in advanced techniques, thereby boosting the overall market for onchocerciasis treatment. For instance, in June 2024, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional body for board-certified aesthetic plastic surgeons, in 2023, nearly 35 million aesthetic procedures were performed worldwide, a 3.4% increase from the previous year. The report also highlighted that surgical procedures rose by 5.5%, with more than 15.8 million procedures performed by plastic surgeons. Therefore, the rising demand for surgical procedures is driving growth in the onchocerciasis treatment market.

Who Are The Major Players In The Global Onchocerciasis Treatment Market?

Major companies operating in the onchocerciasis treatment market are Merck & Co. Inc., Teva Pharmaceutical Industries Limited, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Intas Pharmaceuticals Limited, Dr. Reddy's Laboratories Inc., Cipla Limited, Endo Inc., Lupin Limited, Instituto de Tecnologia em Imunobiológicos Bio-Manguinhos – Fundação Oswaldo Cruz (Fiocruz), AMGIS Lifescience Ltd., Drugs for Neglected Diseases initiative (DNDi), Rakshit Drugs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., OREX Pharma Private Limited, Angle Bio Pharma Pvt. Ltd., Senores Pharmaceuticals Inc., Avenacy LLC, Dolphin Pharma, Cerata Pharmaceuticals Inc.

What Are The Key Trends Of The Global Onchocerciasis Treatment Market? Novel Antiparasitic Medications Driving Growth In The Market Through Improved Efficacy And Access

Major companies operating in the onchocerciasis treatment market are focusing on developing novel antiparasitic medications to improve treatment effectiveness and reduce duration. Antiparasitic medications are drugs designed to eliminate or inhibit parasites such as worms and protozoa that cause infections in humans. For instance, in December 2024, Medicines Development for Global Health (MDGH), an Australia-based non-profit biopharmaceutical company, received approval from the Ghana Food and Drugs Authority (FDA) for Moxidectin 2 mg oral tablets to treat river blindness in individuals aged 4 years and older. This approval enables Ghana to implement community-based mass drug administration programs using moxidectin, which offers greater efficacy and longer-lasting effects compared to ivermectin. With this approval, MDGH aims to expand access to an effective new treatment for onchocerciasis, enabling large-scale community programs in endemic regions.

Need data on a specific region in this market?

Request Regional Data

What Is The Regional Outlook For The Global Onchocerciasis Treatment Market?

North America was the largest region in the onchocerciasis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the onchocerciasis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the onchocerciasis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Onchocerciasis Treatment Market?

The onchocerciasis treatment market consists of revenues earned by entities providing services such as mass drug administration (MDA) campaigns, community-based health outreach, disease surveillance and diagnostics, vector control initiatives, and public health education. The market value includes the value of related goods sold by the service provider or included within the service offering. The onchocerciasis treatment market also includes sales of antiparasitic drugs, diagnostic kits, drug delivery tools, and protective supplies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Onchocerciasis Treatment Industry?

The onchocerciasis treatment market research report is one of a series of new reports from The Business Research Company that provides onchocerciasis treatment market statistics, including the onchocerciasis treatment industry global market size, regional shares, competitors with the onchocerciasis treatment market share, detailed onchocerciasis treatment market segments, market trends, opportunities, and any further data you may need to thrive in the onchocerciasis treatment industry. This onchocerciasis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Author : Abhilash Pyata

Onchocerciasis Treatment Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.11 billion
Revenue Forecast In 2034	$1.48 billion
Growth Rate	CAGR of 7.5% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The onchocerciasis treatment market covered in this report is segmented – 1) By Drug Type: Ivermectin, Doxycycline, Albendazole, Moxidectin 2) By Treatment Strategy: Mass Drug Administration (MDA), Targeted Treatment 3) By Mode Of Administration: Oral, Injectables, Topical 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 5) By End User: Hospitals And Clinics, Home Care Settings, Government And Non-Governmental Programs Subsegments: 1) By Ivermectin: Oral Tablets, Community-Based Mass Drug Administration (MDA) Kits, Fixed-Dose Combination Therapies, Pediatric Formulations 2) By Doxycycline: Oral Capsules, Extended-Release Tablets, Combination With Anti-Wolbachia Therapy, Hospital-Based Prescription Treatments 3) By Albendazole: Single-Dose Oral Tablets, Combination Therapy With Ivermectin, Government-Supplied Preventive Chemotherapy Packages, Over-The-Counter (OTC) Formulations In Endemic Areas 4) By Moxidectin: Oral Tablets, Long-Acting Formulations, Adult-Only Dosing Regimens, Clinical Trial-Based Access Programs
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Merck & Co. Inc., Teva Pharmaceutical Industries Limited, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Intas Pharmaceuticals Limited, Dr. Reddy's Laboratories Inc., Cipla Limited, Endo Inc., Lupin Limited, Instituto de Tecnologia em Imunobiológicos Bio-Manguinhos – Fundação Oswaldo Cruz (Fiocruz), AMGIS Lifescience Ltd., Drugs for Neglected Diseases initiative (DNDi), Rakshit Drugs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., OREX Pharma Private Limited, Angle Bio Pharma Pvt. Ltd., Senores Pharmaceuticals Inc., Avenacy LLC, Dolphin Pharma, Cerata Pharmaceuticals Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Onchocerciasis Treatment Market Characteristics

3. Onchocerciasis Treatment Market Trends And Strategies

4. Onchocerciasis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Onchocerciasis Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Onchocerciasis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Onchocerciasis Treatment Market Growth Rate Analysis

5.4. Global Onchocerciasis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Onchocerciasis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Onchocerciasis Treatment Total Addressable Market (TAM)

6. Onchocerciasis Treatment Market Segmentation

6.1. Global Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Ivermectin

Doxycycline

Albendazole

Moxidectin

6.2. Global Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Mass Drug Administration (MDA)

Targeted Treatment

6.3. Global Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Injectables

Topical

6.4. Global Onchocerciasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

6.5. Global Onchocerciasis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Home Care Settings

Government And Non-Governmental Programs

6.6. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Ivermectin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Tablets

Community-Based Mass Drug Administration (MDA) Kits

Fixed-Dose Combination Therapies

Pediatric Formulations

6.7. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Doxycycline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Capsules

Extended-Release Tablets

Combination With Anti-Wolbachia Therapy

Hospital-Based Prescription Treatments

6.8. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Albendazole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Single-Dose Oral Tablets

Combination Therapy With Ivermectin

Government-Supplied Preventive Chemotherapy Packages

Over-The-Counter (OTC) Formulations In Endemic Areas

6.9. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Moxidectin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Tablets

Long-Acting Formulations

Adult-Only Dosing Regimens

Clinical Trial-Based Access Programs

7. Onchocerciasis Treatment Market Regional And Country Analysis

7.1. Global Onchocerciasis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Onchocerciasis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Onchocerciasis Treatment Market

8.1. Asia-Pacific Onchocerciasis Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Onchocerciasis Treatment Market

9.1. China Onchocerciasis Treatment Market Overview

9.2. China Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Onchocerciasis Treatment Market

10.1. India Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Onchocerciasis Treatment Market

11.1. Japan Onchocerciasis Treatment Market Overview

11.2. Japan Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Onchocerciasis Treatment Market

12.1. Australia Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Onchocerciasis Treatment Market

13.1. Indonesia Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Onchocerciasis Treatment Market

14.1. South Korea Onchocerciasis Treatment Market Overview

14.2. South Korea Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Onchocerciasis Treatment Market

15.1. Western Europe Onchocerciasis Treatment Market Overview

15.2. Western Europe Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Onchocerciasis Treatment Market

16.1. UK Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Onchocerciasis Treatment Market

17.1. Germany Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Onchocerciasis Treatment Market

18.1. France Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Onchocerciasis Treatment Market

19.1. Italy Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Onchocerciasis Treatment Market

20.1. Spain Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Onchocerciasis Treatment Market

21.1. Eastern Europe Onchocerciasis Treatment Market Overview

21.2. Eastern Europe Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Onchocerciasis Treatment Market

22.1. Russia Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Onchocerciasis Treatment Market

23.1. North America Onchocerciasis Treatment Market Overview

23.2. North America Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Onchocerciasis Treatment Market

24.1. USA Onchocerciasis Treatment Market Overview

24.2. USA Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Onchocerciasis Treatment Market

25.1. Canada Onchocerciasis Treatment Market Overview

25.2. Canada Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Onchocerciasis Treatment Market

26.1. South America Onchocerciasis Treatment Market Overview

26.2. South America Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Onchocerciasis Treatment Market

27.1. Brazil Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Onchocerciasis Treatment Market

28.1. Middle East Onchocerciasis Treatment Market Overview

28.2. Middle East Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Onchocerciasis Treatment Market

29.1. Africa Onchocerciasis Treatment Market Overview

29.2. Africa Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Onchocerciasis Treatment Market Competitive Landscape And Company Profiles

30.1. Onchocerciasis Treatment Market Competitive Landscape

30.2. Onchocerciasis Treatment Market Company Profiles

30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Teva Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Hetero Labs Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Sun Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Intas Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis

31. Onchocerciasis Treatment Market Other Major And Innovative Companies

31.1. Dr. Reddy's Laboratories Inc.

31.2. Cipla Limited

31.3. Endo Inc.

31.4. Lupin Limited

31.5. Instituto de Tecnologia em Imunobiológicos Bio-Manguinhos – Fundação Oswaldo Cruz (Fiocruz)

31.6. AMGIS Lifescience Ltd.

31.7. Drugs for Neglected Diseases initiative (DNDi)

31.8. Rakshit Drugs Pvt. Ltd.

31.9. Hangzhou Longshine Bio-Tech Co. Ltd.

31.10. OREX Pharma Private Limited

31.11. Angle Bio Pharma Pvt. Ltd.

31.12. Senores Pharmaceuticals Inc.

31.13. Avenacy LLC

31.14. Dolphin Pharma

31.15. Cerata Pharmaceuticals Inc.

32. Global Onchocerciasis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Onchocerciasis Treatment Market

34. Recent Developments In The Onchocerciasis Treatment Market

35. Onchocerciasis Treatment Market High Potential Countries, Segments and Strategies

35.1 Onchocerciasis Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Onchocerciasis Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Onchocerciasis Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Onchocerciasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Onchocerciasis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Onchocerciasis Treatment Market, Sub-Segmentation Of Ivermectin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Onchocerciasis Treatment Market, Sub-Segmentation Of Doxycycline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Onchocerciasis Treatment Market, Sub-Segmentation Of Albendazole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Onchocerciasis Treatment Market, Sub-Segmentation Of Moxidectin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Onchocerciasis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Onchocerciasis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Merck & Co. Inc. Financial Performance

Table 81: Teva Pharmaceutical Industries Limited Financial Performance

Table 82: Hetero Labs Limited Financial Performance

Table 83: Sun Pharmaceutical Industries Limited Financial Performance

Table 84: Intas Pharmaceuticals Limited Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Onchocerciasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Onchocerciasis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Onchocerciasis Treatment Market, Sub-Segmentation Of Ivermectin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Onchocerciasis Treatment Market, Sub-Segmentation Of Doxycycline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Onchocerciasis Treatment Market, Sub-Segmentation Of Albendazole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Onchocerciasis Treatment Market, Sub-Segmentation Of Moxidectin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Onchocerciasis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Onchocerciasis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Merck & Co. Inc. Financial Performance

Figure 81: Teva Pharmaceutical Industries Limited Financial Performance

Figure 82: Hetero Labs Limited Financial Performance

Figure 83: Sun Pharmaceutical Industries Limited Financial Performance

Figure 84: Intas Pharmaceuticals Limited Financial Performance

Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

$8.21 Billion Forecast for Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market by 2029, Backed by Demand and Innovation

Fentanyl Market Forecast Reaching $22.03 Billion by 2029 at 6.5% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Oncology Companion Diagnostics Global Market Report 2025 – By Product (Instrument, Consumables, Software), By Disease Type (Melanoma, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Other Disease Types), By ...

Oncologists Global Market Report 2025 – By Cancer Diagnostics and Treatment (Cancer Diagnostics, Cancer Treatment), By Indication (Lungs Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, Head and Ne...

Generic Oncology Drugs Global Market Report 2025 – By Molecule Type (Large Molecule, Small Molecule), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pha...

Medicinal Mushroom Global Market Report 2025 – By Type (Shiitake, Reishi, Maitake, Chaga, Cordyceps, Turkey Tail, Other Types), By Form (Fresh, Dried, Other Forms), By Application (Antioxidants, Immune Enhancer, Anti-Can...

Anticholinergic Drugs Global Market Report 2025 – By Type (Synthetic Compounds, Natural, Semi-Synthetic Compounds), By Route Of Administration (Parental, Oral, Topical), By Application (Overactive Bladder, Parkinson Dise...

Antipsychotic Drugs Global Market Report 2025 – By Therapeutic Class (First Generation, Second Generation, Third Generation), By Disease (Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Diseases), B...

Community Oncology Services Global Market Report 2025 – By Type (Small Community Oncology Clinics, Medium Community Oncology Clinics, Large Community Oncology Clinics), By Cancer Type (Breast Cancer, Lung Cancer, Kidney ...

Frequently Asked Questions

What is the definition of the Onchocerciasis Treatment market?

How will the Onchocerciasis Treatment market drivers and restraints affect the market dynamics? What forces will shape the Onchocerciasis Treatment industry going forward?

The Onchocerciasis Treatment market major growth driver - Surge In Eye-related Conditions Fueling Growth Of The Market Due To Rising Risk Of Vision Loss. For further insights on the Onchocerciasis Treatment market, request a sample here

What is the forecast market size or the forecast market value of the Onchocerciasis Treatment market?

The Onchocerciasis Treatment market size has grown strongly in recent years. The onchocerciasis treatment market size has grown strongly in recent years. It will grow from $1.03 billion in 2024 to $1.11 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to an increase in patients suffering from eye-associated issues, an increase in parasitic infections, an increase in the number of targeted treatment centers, a rise in education campaigns, and an increase in the geriatric population. The onchocerciasis treatment market size is expected to see strong growth in the next few years. It will grow to $1.48 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to rising prevalence in endemic regions, rising demand for surgical procedures, expanding healthcare infrastructure, growing prevalence of chronic diseases, and increasing healthcare investments. Major trends in the forecast period include a shift towards single-dose regimens, advancements in macrocyclic lactone formulations, the emergence of Wolbachia-targeting therapies, the integration of artificial intelligence (AI) in drug discovery, and the development of pediatric-specific treatments. For further insights on the Onchocerciasis Treatment market, request a sample here

How is the Onchocerciasis Treatment market segmented?

The onchocerciasis treatment market covered in this report is segmented –
1) By Drug Type: Ivermectin, Doxycycline, Albendazole, Moxidectin
2) By Treatment Strategy: Mass Drug Administration (MDA), Targeted Treatment
3) By Mode Of Administration: Oral, Injectables, Topical
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals And Clinics, Home Care Settings, Government And Non-Governmental Programs

Subsegments:
1) By Ivermectin: Oral Tablets, Community-Based Mass Drug Administration (MDA) Kits, Fixed-Dose Combination Therapies, Pediatric Formulations
2) By Doxycycline: Oral Capsules, Extended-Release Tablets, Combination With Anti-Wolbachia Therapy, Hospital-Based Prescription Treatments
3) By Albendazole: Single-Dose Oral Tablets, Combination Therapy With Ivermectin, Government-Supplied Preventive Chemotherapy Packages, Over-The-Counter (OTC) Formulations In Endemic Areas
4) By Moxidectin: Oral Tablets, Long-Acting Formulations, Adult-Only Dosing Regimens, Clinical Trial-Based Access Programs For further insights on the Onchocerciasis Treatment market, request a sample here

Which region has the largest share of the Onchocerciasis Treatment market? What are the other regions covered in the report?

Who are the major players in the Onchocerciasis Treatment market?

What are the key trends in the Onchocerciasis Treatment market?

Major trends in the Onchocerciasis Treatment market include Novel Antiparasitic Medications Driving Growth In The Market Through Improved Efficacy And Access. For further insights on the Onchocerciasis Treatment market, request a sample here.